State Street Corp Coll Plant Biotechnologies LTD Transaction History

State Street Corp

  • $2.21 Trillion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$12.0 - $22.48 $2.19 Million - $4.1 Million
-182,266 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$16.0 - $21.75 $92,416 - $125,628
5,776 Added 3.27%
182,266 $3.08 Million
Q2 2021

Aug 16, 2021
BUY
$13.55 - $22.45 $2.39 Million - $3.96 Million
176,490 New
176,490 $3.74 Million

Others Institutions Holding CLGN

# of Institutions
16
Shares Held
1.88M
Call Options Held
200
Put Options Held
500
View Full List

About CollPlant Biotechnologies Ltd

CLGN Quotes by TradingView
  • Ticker CLGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,086,500
  • Market Cap $55M
  • Description
  • CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...
More about CLGN
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email